asthma (961) inhalation (98) inhaler (32) dry-powder (6) fluticasone propionate (3) salmeterol (3) inhalation powder (1) twice-daily dose (1) airduo respiclick® (1)
that offers the lowest approved dose of fluticasone propionate and salmeterol at each strength 1-4
AirDuo RespiClick ® is indicated for the treatment of asthma in patients aged 12 years and older. AirDuo RespiClick is only for patients uncontrolled on an inhaled corticosteroid (ICS) or whose disease severity clearly warrants an ICS/Long-acting beta 2 -agonist (LABA).
Limitation of Use: AirDuo RespiClick is not indicated for the relief of acute bronchospasm.